Earnings Call Excerpt
Teva Pharmaceuticals (TEVA)
Q3 2006 Earnings Call
November 7, 2006 8:45 am ET
Executives:
Israel Makov, President and Chief Executive Officer
Moshe Manor, Group Vice President, Global Products
Dan Suesskind, CFO
William Marth, President & CEO, Teva Pharmaceuticals USA
George Barrett, Group VP, North America, President & CEO, North America
Kevin Mannix, Director Investor Relations
Analysts:
Greg Gilbert, Merrill Lynch
Rich Silver, Lehman Brothers
Robert Bonte-Friedheim, Citigroup
Ken Cacciatore, Cowen & Co
Doug Landy, CIBC World Markets
Randall Fenicki, Goldman Sachs
Marc Goodman, Credit Suisse
Ron Miguel, Sanford Bernstein
Louise Chen, Morgan Stanley
Adam Greene, JP Morgan
David Buck, Buckingham Research
William Sawyer, Leerink Swann
Corey Davis, Natexis Bleichroeder
Presentation
Operator
Greetings ladies and gentlemen and welcome to the Teva Pharmaceutical Industries Ltd. Third Quarter 2006 Earnings Results Conference Call. At this time, all participants are in a listen-only mode. A brief question and answer session will follow the formal presentation. If anyone should require operator assistance during the conference, please press * and 0 on your telephone keypad. As a reminder, this conference is being recorded. It is now my pleasure to introduce your host, Mr. Kevin Mannix, North American Director of Investor Relations for Teva Pharmaceutical Industries Ltd. Thank you, Mr. Mannix, you may begin.
Kevin Mannix, Director Investor Relations
Thank you, Dan. Good morning and good afternoon everyone, welcome to Teva’s Third Quarter 2006 Earnings Conference Call. We hope you’ve all had a chance to review our press release which we issued earlier this morning. A copy of the press release is available on our website at www.tevapharm.com. Additionally, we are conducting a live webcast of this call which is also available on our website. Today, we are joined by Israel Makov, President and CEO; Dan Suesskind, Chief Financial Officer; George Barrett, President and CEO of Teva North America; Bill Marth, President & CEO of Teva USA; and Moshe Manor, Vice President of Global Products. Israel and Dan will begin by providing an overview of our results. We will then open up the call for a question and answer period.
I’d also like to remind all of you that we will host a special quarterly luncheon today in New York. For those of you who haven’t received our invitation or have not yet RSVP’d, please call us at 215-591-3056, and if you’re unable to join us we are conducting a live webcast of the event, which will also be available on our website.
- To read the full transcript on Seeking Alpha, click here »
